Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.D., Catholic University (Italy) 1986
• 

  Duke Appointment History

  • Associate Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Addiction, Psychiatry & Behavioral Sciences 2006 - 2014
  • Associate Clinical Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2005 - 2006
  • Associate Research Professor of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2005
  • Clinical Associate in the Department of Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Translational Neuroscience, Psychiatry & Behavioral Sciences 2004 - 2005
• Research
• 

  Selected Grants

  • Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace awarded by University of Minnesota 2018 - 2022
  • Alkermes ALK6428-A302 awarded by Alkermes, plc 2017 - 2020
  • Effects of Nicotine Reduction on Smoking Behavior in ADHD Smokers awarded by National Institutes of Health 2015 - 2020
  • Mid Southern Primary Care Networks Node awarded by National Institutes of Health 2015 - 2020
  • Substance Abuse & Treatment Gaps in Asians, Pacific Islanders & Multiple-race Individuals awarded by National Institutes of Health 2013 - 2020
  • ALK648-A301 - NXT-VIV awarded by Alkermes, plc 2016 - 2019
  • A feasibility study for testing the effects of extended-release naltrexone (Vivitrol) on recidivism and other participant outcomes in drug court settings awarded by Laura and John Arnold Foundation 2016 - 2019
  • Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers awarded by National Institutes of Health 2016 - 2019
  • RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse awarded by National Institutes of Health 2013 - 2019
  • Retrospective Evaluation of Zubsolv Outcomes - A Longitudinal View (REZOLV) awarded by OREXO 2015 - 2018
  • Carolinas Comprehensive Substance Abuse Services Project awarded by Substance Abuse and Mental Health Services Administration 2012 - 2018
  • Impact of Very Low Nicotine Content Cigarettes in a Complex Marketplace awarded by University of Minnesota 2017
  • Project 2: Evaluating New Nicotine Standards for Cigarettes - Supplement awarded by University of Minnesota 2014 - 2017
  • Southern Consortium Node of the Clinical Trials Network awarded by Medical University of South Carolina 2013 - 2015
  • Carolina Alcohol and Drug Expansion Team (CADET) awarded by Department of Health and Human Services 2007 - 2013
  • Epidemiology of Non-Medical Prescription Analgesic Use awarded by National Institutes of Health 2007 - 2012
  • Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Use/Abuse awarded by National Institutes of Health 2008 - 2011
  • Place of Low-Dose Naltrexone in Opiate Detoxification awarded by National Institutes of Health 2004 - 2006
  • Serotonin and Cocaine Dependence awarded by National Institutes of Health 2003 - 2006
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • John, WS, Zhu, H, Mannelli, P, Subramaniam, GA, Schwartz, RP, McNeely, J, and Wu, L-T. "Prevalence and patterns of opioid misuse and opioid use disorder among primary care patients who use tobacco." Drug and Alcohol Dependence 194 (January 2019): 468-475.  Full Text
    • Mannelli, P, and Wu, L-T. "Opioid use disorder deaths and the effects of medication therapy." The American Journal of Drug and Alcohol Abuse 45, no. 3 (January 2019): 227-229.  Full Text
    • Mannelli, P, Swartz, M, and Wu, L-T. "Withdrawal severity and early response to treatment in the outpatient transition from opioid use to extended release naltrexone." The American Journal on Addictions 27, no. 6 (September 2018): 471-476.  Full Text
    • Proeschold-Bell, RJ, Evon, DM, Makarushka, C, Wong, JB, Datta, SK, Yao, J, Patkar, AA, Mannelli, P, Hodge, T, Naggie, S, Wilder, JM, Fried, MW, Niedzwiecki, D, and Muir, AJ. "The Hepatitis C-Alcohol Reduction Treatment (Hep ART) intervention: Study protocol of a multi-center randomized controlled trial." Contemporary Clinical Trials 72 (September 2018): 73-85.  Full Text
    • Bisaga, A, Mannelli, P, Yu, M, Nangia, N, Graham, CE, Tompkins, DA, Kosten, TR, Akerman, SC, Silverman, BL, and Sullivan, MA. "Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial." Drug and Alcohol Dependence 187 (June 2018): 171-178.  Full Text
    • John, WS, Zhu, H, Mannelli, P, Schwartz, RP, Subramaniam, GA, and Wu, L-T. "Prevalence, patterns, and correlates of multiple substance use disorders among adult primary care patients." Drug and Alcohol Dependence 187 (June 2018): 79-87.  Full Text
    • Wu, L-T, Ghitza, UE, Zhu, H, Spratt, S, Swartz, M, and Mannelli, P. "Substance use disorders and medical comorbidities among high-need, high-risk patients with diabetes." Drug and Alcohol Dependence 186 (May 2018): 86-93.  Full Text
    • Bisaga, A, Mannelli, P, Sullivan, MA, Vosburg, SK, Compton, P, Woody, GE, and Kosten, TR. "Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies." The American journal on addictions 27, no. 3 (April 2018): 177-187. (Review)  Full Text
    • Wu, L-T, Zhu, H, Mannelli, P, and Swartz, MS. "Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States." Drug and Alcohol Dependence 177 (August 2017): 153-162.  Full Text
    • Wu, L-T, Ghitza, UE, Burns, AL, and Mannelli, P. "The opioid overdose epidemic: opportunities for pharmacists." Substance Abuse and Rehabilitation 8 (January 2017): 53-55.  Full Text  Open Access Copy
    • Mannelli, P, and Wu, L-T. "Family substance use screening: less to hide, more to gain." The Indian Journal of Medical Research 143, no. 6 (June 2016): 682-684.  Full Text  Open Access Copy
    • Mannelli, P, and Wu, L-T. "Primary care for opioid use disorder." Substance Abuse and Rehabilitation 7 (January 2016): 107-109.  Full Text  Open Access Copy
    • Mannelli, P, Wu, L-T, Peindl, KS, Swartz, MS, and Woody, GE. "Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: a very low dose naltrexone and buprenorphine open label trial." Drug and Alcohol Dependence 138 (May 2014): 83-88.  Full Text
    • Mannelli, P, Wu, LT, Peindl, KS, Swartz, MS, and Woody, GE. "Extended release naltrexone injection is performed in the majority of opioid dependent patients receiving outpatient induction: A very low dose naltrexone and buprenorphine open label trial." Drug and Alcohol Dependence 138, no. 1 (May 1, 2014): 83-88.  Full Text
    • Wu, L-T, Brady, KT, Mannelli, P, Killeen, TK, and NIDA AAPI Workgroup, . "Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: a national study." Journal of Psychiatric Research 50 (March 2014): 26-35.  Full Text
    • Proeschold-Bell, RJ, Reif, S, Taylor, B, Patkar, A, Mannelli, P, Yao, J, and Quinlivan, EB. "Substance Use Outcomes of an Integrated HIV-Substance Use Treatment Model Implemented by Social Workers and HIV Medical Providers." Health and Social Work 41, no. 1 (February 24, 2014): e1-e10.  Full Text
    • Wu, LT, Brady, KT, Mannelli, P, and Killeen, TK. "Cannabis use disorders are comparatively prevalent among nonwhite racial/ethnic groups and adolescents: A national study." Journal of Psychiatric Research 50, no. 1 (January 1, 2014): 26-35.  Full Text
    • Wu, L-T, Blazer, DG, Gersing, KR, Burchett, B, Swartz, MS, Mannelli, P, and NIDA AAPI Workgroup, . "Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people." J Psychiatr Res 47, no. 12 (December 2013): 1940-1948.  Full Text  Link to Item
    • Mannelli, P, Wu, L-T, Peindl, KS, and Gorelick, DA. "Smoking and opioid detoxification: behavioral changes and response to treatment." Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco 15, no. 10 (October 2013): 1705-1713.  Full Text
    • Mannelli, P. "The burden of caring: drug users & their families." Indian J Med Res 137, no. 4 (April 2013): 636-638.  Link to Item
    • Wu, L-T, Swartz, MS, Pan, J-J, Burchett, B, Mannelli, P, Yang, C, and Blazer, DG. "Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults." General Hospital Psychiatry 35, no. 1 (January 2013): 74-82.  Full Text
    • Wu, LT, Blazer, DG, Gersing, KR, Burchett, B, Swartz, MS, and Mannelli, P. "Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people." Journal of Psychiatric Research 47, no. 12 (2013): 1940-1948.  Full Text
    • Wu, LT, Swartz, MS, Pan, JJ, Burchett, B, Mannelli, P, Yang, C, and Blazer, DG. "Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults." General Hospital Psychiatry 35, no. 1 (2013): 74-82.  Full Text
    • Wu, L-T, Swartz, MS, Wu, Z, Mannelli, P, Yang, C, and Blazer, DG. "Alcohol and drug use disorders among adults in emergency department settings in the United States." Annals of Emergency Medicine 60, no. 2 (August 2012): 172-80.e5.  Full Text
    • Lee, TH, Szabo, ST, Fowler, JC, Mannelli, P, Mangum, OB, Beyer, WF, Patkar, A, and Wetsel, WC. "Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy." Drug Alcohol Depend 124, no. 1-2 (July 1, 2012): 11-18. (Review)  Full Text  Link to Item
    • Mannelli, P, Peindl, K, Wu, L-T, Patkar, AA, and Gorelick, DA. "The combination very low-dose naltrexone-clonidine in the management of opioid withdrawal." The American Journal of Drug and Alcohol Abuse 38, no. 3 (May 2012): 200-205.  Full Text
    • Proeschold-Bell, RJ, Patkar, AA, Naggie, S, Coward, L, Mannelli, P, Yao, J, Bixby, P, and Muir, AJ. "An integrated alcohol abuse and medical treatment model for patients with hepatitis C." Dig Dis Sci 57, no. 4 (April 2012): 1083-1091.  Full Text  Open Access Copy  Link to Item
    • Mannelli, P, Peindl, KS, Lee, T, Bhatia, KS, and Wu, L-T. "Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives." Current Drug Abuse Reviews 5, no. 1 (March 2012): 52-63. (Review)  Full Text
    • Mannelli, P. "Once-monthly extended-release naltrexone injections improve opioid abstinence over 24 weeks compared with placebo." Evid Based Ment Health 14, no. 4 (November 2011): 106-.  Full Text  Link to Item
    • Mannelli, P, Peindl, KS, and Wu, L-T. "Pharmacological enhancement of naltrexone treatment for opioid dependence: a review." Substance Abuse and Rehabilitation 2011, no. 2 (June 2011): 113-123.  Full Text  Open Access Copy
    • Mannelli, P, Peindl, K, Patkar, AA, Wu, L-T, Tharwani, HM, and Gorelick, DA. "Problem drinking and low-dose naltrexone-assisted opioid detoxification." Journal of Studies on Alcohol and Drugs 72, no. 3 (May 2011): 507-513.
    • Wu, L-T, Woody, GE, Yang, C, Mannelli, P, and Blazer, DG. "Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions." Substance Abuse and Rehabilitation 2011, no. 2 (May 2011): 77-88.  Full Text  Open Access Copy
    • Mannelli, P, Peindl, K, Patkar, AA, Wu, L-T, Pae, C-U, and Gorelick, DA. "Reduced cannabis use after low-dose naltrexone addition to opioid detoxification." Journal of Clinical Psychopharmacology 30, no. 4 (August 2010): 476-478. (Letter)  Full Text
    • Mannelli, P. "Agonist-antagonist combinations in opioid dependence: a translational approach." Dipendenze Patologiche 5, no. 1 (January 2010): 17-24.
    • Mannelli, P, Patkar, A, Rozen, S, Matson, W, Krishnan, R, and Kaddurah-Daouk, R. "Opioid use affects antioxidant activity and purine metabolism: preliminary results." Hum Psychopharmacol 24, no. 8 (December 2009): 666-675.  Full Text  Link to Item
    • Patkar, AA, Rozen, S, Mannelli, P, Matson, W, Pae, C-U, Krishnan, KR, and Kaddurah-Daouk, R. "Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study." Psychopharmacology (Berl) 206, no. 3 (October 2009): 479-489.  Full Text  Link to Item
    • Pae, C-U, Masand, PS, Marks, DM, Krulewicz, S, Peindl, K, Mannelli, P, and Patkar, AA. "History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia." Prog Neuropsychopharmacol Biol Psychiatry 33, no. 6 (August 31, 2009): 996-1002.  Full Text  Link to Item
    • Wu, L-T, Parrott, AC, Ringwalt, CL, Patkar, AA, Mannelli, P, and Blazer, DG. "The high prevalence of substance use disorders among recent MDMA users compared with other drug users: Implications for intervention." Addictive Behaviors 34, no. 8 (August 2009): 654-661.  Full Text
    • Mannelli, P, Patkar, AA, Peindl, K, Gorelick, DA, Wu, L-T, and Gottheil, E. "Very low dose naltrexone addition in opioid detoxification: a randomized, controlled trial." Addiction Biology 14, no. 2 (April 2009): 204-213.  Full Text
    • Mannelli, P, Patkar, AA, Peindl, K, Gottheil, E, Wu, L-T, and Gorelick, DA. "Early outcomes following low dose naltrexone enhancement of opioid detoxification." The American Journal on Addictions 18, no. 2 (March 2009): 109-116.  Full Text
    • Pae, C-U, Marks, DM, Masand, PS, Peindl, K, Hooper-Wood, C, Han, C, Mannelli, P, Ciccone, P, and Patkar, AA. "Methylphenidate extended release (OROS MPH) for the treatment of antidepressant-related sexual dysfunction in patients with treatment-resistant depression: results from a 4-week, double-blind, placebo-controlled trial." Clin Neuropharmacol 32, no. 2 (March 2009): 85-88.  Full Text  Link to Item
    • Han, C, Masand, PS, Krulewicz, S, Peindl, K, Mannelli, P, Varia, IM, Pae, C-U, and Patkar, AA. "Childhood abuse and treatment response in patients with irritable bowel syndrome: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release." J Clin Pharm Ther 34, no. 1 (February 2009): 79-88.  Full Text  Link to Item
    • Masand, PS, Pae, C-U, Krulewicz, S, Peindl, K, Mannelli, P, Varia, IM, and Patkar, AA. "A double-blind, randomized, placebo-controlled trial of paroxetine controlled-release in irritable bowel syndrome." Psychosomatics 50, no. 1 (January 2009): 78-86.  Full Text  Link to Item
    • Pae, C-U, Masand, PS, Marks, DM, Krulewicz, S, Han, C, Peindl, K, Mannelli, P, and Patkar, AA. "History of early abuse as a predictor of treatment response in patients with fibromyalgia: a post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release." World J Biol Psychiatry 10, no. 4 Pt 2 (2009): 435-441.  Full Text  Link to Item
    • Pae, C-U, Masand, PS, Marks, DM, Krulewicz, S, Han, C, Peindl, K, Mannelli, P, and Patkar, AA. "History of early abuse as a predictor of treatment response in patients with fibromyalgia: A post-hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release." The World Journal of Biological Psychiatry 10, no. 4-2 (January 2009): 435-441.  Full Text
    • Patkar, AA, Mannelli, P, Peindl, K, Hill, KP, Wu, L-T, Lee, T, and Kuhn, C. "Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence." Journal of Psychiatric Research 42, no. 14 (October 2008): 1213-1219.  Full Text
    • Wu, L-T, Ringwalt, CL, Mannelli, P, and Patkar, AA. "Hallucinogen use disorders among adult users of MDMA and other hallucinogens." The American Journal on Addictions 17, no. 5 (September 2008): 354-363.  Full Text
    • Wu, L-T, Ringwalt, CL, Mannelli, P, and Patkar, AA. "Prescription pain reliever abuse and dependence among adolescents: a nationally representative study." Journal of the American Academy of Child and Adolescent Psychiatry 47, no. 9 (September 2008): 1020-1029.  Full Text
    • Pae, CU, Masand, PS, Peindl, K, Hooper-Wood, C, Han, C, Mannelli, P, Ciccone, P, and Patkar, AA. "Reply to Dr Ng's comments on "A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation with An Extended Release Formulation of Methylphenidate in Outpatients with Treatment-Resistant Depression" [11]." Journal of Clinical Psychopharmacology 28, no. 1 (February 1, 2008): 117-118. (Letter)  Full Text
    • Pae, C-U, Masand, PS, Peindl, K, Mannelli, P, Han, C, Marks, DM, and Patkar, AA. "An open-label, rater-blinded, flexible-dose, 8-week trial of escitalopram in patients with major depressive disorder with atypical features." Prim Care Companion J Clin Psychiatry 10, no. 3 (2008): 205-210.  Link to Item
    • Peindl, KS, Masand, P, Mannelli, P, Narasimhan, M, and Patkar, A. "Polypharmacy in pregnant women with major psychiatric illness: a pilot study." J Psychiatr Pract 13, no. 6 (November 2007): 385-392.  Full Text  Link to Item
    • Mannelli, P, Patkar, AA, Peindl, K, Murray, HW, Wu, L-T, and Hubbard, R. "Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence." Journal of Clinical Psychopharmacology 27, no. 5 (October 2007): 468-474.  Full Text
    • Mannelli, P, Peindl, K, Masand, PS, and Patkar, AA. "Long-acting injectable naltrexone for the treatment of alcohol dependence." Expert Rev Neurother 7, no. 10 (October 2007): 1265-1277. (Review)  Full Text  Link to Item
    • Peindl, KS, Mannelli, P, Wu, L-T, and Patkar, AA. "Trends in nonheroin opioid abuse admissions: 1992-2004." Journal of Opioid Management 3, no. 4 (July 2007): 215-223.
    • Davidson, C, Gopalan, R, Ahn, C, Chen, Q, Mannelli, P, Patkar, AA, Weese, GD, Lee, TH, and Ellinwood, EH. "Reduction in methamphetamine induced sensitization and reinstatement after combined pergolide plus ondansetron treatment during withdrawal." Eur J Pharmacol 565, no. 1-3 (June 22, 2007): 113-118.  Full Text  Link to Item
    • Mannelli, P, and Pae, CU. "Medical comorbidity and alcohol dependence." Curr Psychiatry Rep 9, no. 3 (June 2007): 217-224. (Review)  Link to Item
    • Tharwani, HM, Yerramsetty, P, Mannelli, P, Patkar, A, and Masand, P. "Recent advances in poststroke depression." Curr Psychiatry Rep 9, no. 3 (June 2007): 225-231. (Review)  Link to Item
    • Patkar, AA, Masand, PS, Krulewicz, S, Mannelli, P, Peindl, K, Beebe, KL, and Jiang, W. "A randomized, controlled, trial of controlled release paroxetine in fibromyalgia." Am J Med 120, no. 5 (May 2007): 448-454.  Full Text  Link to Item
    • Patkar, AA, Masand, PS, Pae, C-U, Peindl, K, Hooper-Wood, C, Mannelli, P, and Ciccone, P. "A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression." Journal of Clinical Psychopharmacology 26, no. 6 (December 2006): 653-656.  Full Text
    • Mannelli, P, Patkar, AA, Peindl, K, Tharwani, H, Gopalakrishnan, R, Hill, KP, and Berrettini, WH. "Polymorphism in the serotonin transporter gene and moderators of prolactin response to meta-chlorophenylpiperazine in African-American cocaine abusers and controls." Psychiatry Res 144, no. 2-3 (November 15, 2006): 99-108.  Full Text  Link to Item
    • Patkar, AA, Mannelli, P, Hill, KP, Peindl, K, Pae, C-U, and Lee, TH. "Relationship of prolactin response to meta-chlorophenylpiperazine with severity of drug use in cocaine dependence." Human Psychopharmacology 21, no. 6 (August 2006): 367-375.  Full Text
    • Patkar, AA, Mannelli, P, Peindl, K, Hill, KP, Gopalakrishnan, R, and Berrettini, WH. "Relationship of disinhibition and aggression to blunted prolactin response to meta-chlorophenylpiperazine in cocaine-dependent patients." Psychopharmacology 185, no. 1 (March 2006): 123-132.  Full Text
    • Van Bockstaele, EJ, Rudoy, C, Mannelli, P, Oropeza, V, and Qian, Y. "Elevated mu-opioid receptor expression in the nucleus of the solitary tract accompanies attenuated withdrawal signs after chronic low dose naltrexone in opiate-dependent rats." J Neurosci Res 83, no. 3 (February 15, 2006): 508-514.  Full Text  Link to Item
    • Mannelli, P, Gottheil, E, and Van Bockstaele, EJ. "Antagonist treatment of opioid withdrawal translational low dose approach." Journal of Addictive Diseases 25, no. 2 (January 2006): 1-8. (Review)  Full Text
    • Patkar, AA, Mannelli, P, Peindl, K, Murray, HW, Meier, B, and Leone, FT. "Changes in tobacco smoking following treatment for cocaine dependence." The American Journal of Drug and Alcohol Abuse 32, no. 2 (January 2006): 135-148.  Full Text
    • Patkar, AA, Peindl, K, Mago, R, Mannelli, P, and Masand, PS. "An open-label, rater-blinded, augmentation study of aripiprazole in treatment-resistant depression." Prim Care Companion J Clin Psychiatry 8, no. 2 (2006): 82-87.  Link to Item
    • Ray, R, Doyle, GA, Crowley, JJ, Buono, RJ, Oslin, DW, Patkar, AA, Mannelli, P, DeMaria, PA, O'Brien, CP, and Berrettini, WH. "A functional prodynorphin promoter polymorphism and opioid dependence." Psychiatr Genet 15, no. 4 (December 2005): 295-298.  Link to Item
    • Mannelli, P, Patkar, AA, Murray, HW, Certa, K, Peindl, K, Mattila-Evenden, M, and Berrettini, WH. "Polymorphism in the serotonin transporter gene and response to treatment in African American cocaine and alcohol-abusing individuals." Addiction Biology 10, no. 3 (September 2005): 261-268.  Full Text
    • Smith, RJ, Doyle, GA, Han, AM, Crowley, JJ, Oslin, DW, Patkar, AA, Mannelli, P, Demaria, PA, O'brien, CP, and Berrettini, WH. "Novel exonic mu-opioid receptor gene (OPRM1) polymorphisms not associated with opioid dependence." American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics 133B, no. 1 (February 2005): 105-109.  Full Text
    • Patkar, AA, Batra, V, Mannelli, P, Evers-Casey, S, Vergare, MJ, and Leone, FT. "Medical symptoms associated with tobacco smoking with and without marijuana abuse among crack cocaine-dependent patients." Am J Addict 14, no. 1 (January 2005): 43-53.  Full Text  Link to Item
    • McCarthy, LE, Mannelli, P, Niculescu, M, Gingrich, K, Unterwald, EM, and Ehrlich, ME. "The distribution of cocaine in mice differs by age and strain." Neurotoxicol Teratol 26, no. 6 (November 2004): 839-848.  Full Text  Link to Item
    • Patkar, AA, Mannelli, P, Certa, KM, Peindl, K, Murray, H, Vergare, MJ, and Berrettini, WH. "Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence." Psychopharmacology 176, no. 1 (October 2004): 74-81.  Full Text
    • Mannelli, P, Gottheil, E, Peoples, JF, Oropeza, VC, and Van Bockstaele, EJ. "Chronic very low dose naltrexone administration attenuates opioid withdrawal expression." Biological Psychiatry 56, no. 4 (August 2004): 261-268.  Full Text
    • Patkar, AA, Berrettini, WH, Mannelli, P, Gopalakrishnan, R, Hoehe, MR, Bilal, L, Weinstein, S, and Vergare, MJ. "Relationship between serotonin transporter gene polymorphisms and platelet serotonin transporter sites among African-American cocaine-dependent individuals and healthy volunteers." Psychiatric Genetics 14, no. 1 (March 2004): 25-32.  Full Text
    • Patkar, AA, Murray, HW, Mannelli, P, Gottheil, E, Weinstein, SP, and Vergare, MJ. "Pre-treatment measures of impulsivity, aggression and sensation seeking are associated with treatment outcome for African-American cocaine-dependent patients." Journal of Addictive Diseases 23, no. 2 (January 2004): 109-122.  Full Text
    • Patkar, AA, Thornton, CC, Mannelli, P, Hill, KP, Gottheil, E, Vergare, MJ, and Weinstein, SP. "Comparison of pretreatment characteristics and treatment outcomes for alcohol-, cocaine-, and multisubstance-dependent patients." Journal of Addictive Diseases 23, no. 1 (January 2004): 93-109.  Full Text
    • Murray, HW, Patkar, AA, Mannelli, P, DeMaria, P, Desai, AM, and Vergare, MJ. "Relationship of Aggression, Sensation Seeking, and Impulsivity, with Severity of Cocaine Use." Addictive Disorders and Their Treatment 2, no. 4 (December 16, 2003): 113-121.  Full Text
    • Thornton, CC, Patkar, AA, Murray, HW, Mannelli, P, Gottheil, E, Vergare, MJ, and Weinstein, SP. "High- and low-structure treatments for substance dependence: role of learned helplessness." Am J Drug Alcohol Abuse 29, no. 3 (August 2003): 567-584.  Link to Item
    • Mannelli, P, Gottheil, E, Buonanno, A, and De Risio, S. "Use of very low-dose naltrexone during opiate detoxification." J Addict Dis 22, no. 2 (2003): 63-70.  Full Text  Link to Item
    • Pozzi, G, Del Borgo, C, Del Forno, A, Genualdo, A, Mannelli, P, and Fantoni, M. "Psychological discomfort and mental illness in patients with AIDS: implications for home care." AIDS Patient Care STDS 13, no. 9 (September 1999): 555-564.  Full Text  Link to Item
    • De Giacomo, M, Gaspari, R, Stefanelli, A, Barelli, A, and Mannelli, P. "Emergency therapeutical approach simulating ultrarapid opioid detoxification in methadone withdrawal precipitated by erroneous administration of naltrexone." Eur J Emerg Med 6, no. 2 (June 1999): 153-155.  Link to Item
    • Mannelli, P, De Risio, S, Pozzi, G, Janiri, L, and De Giacomo, M. "Serendipitous rapid detoxification from opiates: the importance of time-dependent processes." Addiction (Abingdon, England) 94, no. 4 (April 1999): 589-591.  Full Text
    • Janiri, L, Hadjichristos, A, Buonanno, A, Rago, R, Mannelli, P, and de Risio, S. "Adjuvant trazodone in the treatment of alcoholism: an open study." Alcohol Alcohol 33, no. 4 (July 1998): 362-365.  Link to Item
    • Janiri, L, Gobbi, G, Mannelli, P, Pozzi, G, Serretti, A, and Tempesta, E. "Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics." Int Clin Psychopharmacol 11, no. 2 (June 1996): 109-117.  Link to Item
    • Janiri, L, Mannelli, P, Persico, AM, Serretti, A, and Tempesta, E. "Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine." Drug Alcohol Depend 36, no. 2 (October 1994): 139-145.  Link to Item
    • Janiri, L, Mannelli, P, Serretti, A, and Tempesta, E. "Low-dose buprenorphine detoxification in long term methadone addicts." Regulatory Peptides 53, no. SUPPL. 1 (February 21, 1994).  Full Text
    • Mannelli, P, Janiri, L, Mizzoni, MC, and Tempesta, E. "Sources of differentiation of cocaine withdrawal symptomatology." European Neuropsychopharmacology 4, no. 3 (January 1, 1994): 400-null.  Full Text
    • Mannelli, P, Janiri, L, Tempesta, E, and Jones, RT. "Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine." The British Journal of Psychiatry. Supplement , no. 21 (September 1993): 39-45.
    • Bartoloni, C, Guidi, L, di Giovanni, AL, Antico, L, Cursi, F, Pili, R, Tricerri, A, Janiri, L, Mannelli, P, Pariante, C, Menini, E, Carbonin, P, and Gambassi, G. "Psychological status, life and social conditions: A study in a population of institutionalized elderly people." International Journal of Geriatric Psychiatry 8, no. 5 (January 1, 1993): 419-426.  Full Text
    • Mannelli, P, Janiri, L, Tempesta, E, and Jones, RT. "Prediction in drug abuse: Cocaine interactions with alcohol and buprenorphine." British Journal of Psychiatry 163, no. SEPT. SUPPL. 21 (January 1, 1993): 39-45.
    • Mannelli, P, Mazza, S, Janiri, L, and Tempesta, E. "Serotoninergic hypothesis on the drug mechanism of cocaine." Bollettino Di Psichiatria Biologica 7, no. 3 (December 1, 1991): 56-59.
    • Janiri, L, Di Giovanni, A, Persico, A, Zeppetelli, E, Mannelli, P, Antico, L, and Tempesta, E. "Benzodiazepine use and dependency risk in geriatric inpatients." Minerva Psichiatrica 32, no. 3 (October 28, 1991): 151-163.
    • Janiri, L, Di Giovanni, A, Persico, A, Zeppetelli, E, Mannelli, P, Antico, L, and Tempesta, E. "[Benzodiazepines consumption and risk of dependence in institutionalized geriatric patients]." Minerva Psichiatrica 32, no. 3 (July 1991): 151-163.
    • Janiri, L, Mannelli, P, Persico, AM, Diodato, S, and Tempesta, E. "Zipeprol is a newly abused antitussive with an opioid spectrum and hallucinogenic effects." Drug Alcohol Depend 27, no. 2 (March 1991): 121-125.  Link to Item
    • Janiri, L, Giovanni, AD, Persico, A, Zeppetelli, E, Mannelli, P, Antico, L, and Tempesta, E. "Benzodiazepine use and dependency risk in geriatric inpatients." Minerva Psichiatrica 32, no. 3 (1991): 151-163.
    • Mannelli, P, Mazza, S, Janiri, L, and Tempesta, E. "Serotoninergic hypothesis on the drug mechanism of cocaine." Bollettino di Psichiatria Biologica 7, no. 3 (1991): 56-59.
    • Tempesta, E, Janiri, L, and Mannelli, P. "Patterns of cocaine abuse and indications for treatment." European Neuropsychopharmacology 1, no. 3 (January 1, 1991): 259-261.  Full Text
    • Tempesta, E, Janiri, L, Mannelli, P, Persico, AM, and Diodato, S. "Clinical reports on recent abuse of an antitussive." Br J Addict 85, no. 6 (June 1990): 815-816. (Letter)  Link to Item
    • Mannelli, P, Janiri, L, De Marinis, M, and Tempesta, E. "Lefetamine: new abuse of an old drug--clinical evaluation of opioid activity." Drug Alcohol Depend 24, no. 2 (October 1989): 95-101.  Link to Item
    • Janiri, L, Mannelli, P, Pirrongelli, C, Lo Monaco, M, and Tempesta, E. "Lephetamine abuse and dependence: clinical effects and withdrawal syndrome." Br J Addict 84, no. 1 (January 1989): 89-95.  Link to Item

  • Book Sections

    • Mannelli, P, Wu, LT, and Brady, KT. "Pharmacological and Integrated Treatments in Older Adults with Substance Use Disorders." In Substance Use and Older People, 273-294. December 31, 2015.  Full Text

  • Conference Papers

    • Mannelli, P, Tompkins, DA, Akerman, S, Yu, M, Nangia, N, Graham, C, Sullivan, M, Kosten, T, and Bisaga, A. "Transition to Extended-release Naltrexone: Heroin Versus Prescription Opioid Users." : WILEY, June 1, 2018.  Link to Item
    • Sullivan, M, Mannelli, P, Yu, M, Nangia, N, Graham, C, Webster, I, Tompkins, DA, Kosten, T, Akerman, S, and Silverman, B. "Outpatient Transition to Extended-release Naltrexone in Patients With Opioid-use Disorder." : WILEY, June 1, 2018.  Link to Item
    • Patkar, AA, Masand, PS, Krulewicz, S, Mannelli, P, Peindl, K, Beebe, KL, and Jiang, W. "A randomized, controlled, trial of controlled release paroxetine in fibromyalgia." 157th Annual Meeting of the American-Psychiatric-Association. New York, NY. May 1, 2004 - May 6, 2004.: ELSEVIER SCIENCE INC, May 1, 2007.  Full Text  Link to Item
    • Gopalan, R, Ahn, C, Mannelli, P, Patkar, A, Weese, D, Lee, T, Ellinwood, E, and Davidson, C. "Bupropion reinstates cocaine seeking behavior in rats." 45th Annual Meeting of the American-College-of-Neuropsychopharmacolgy. Hollywood, FL. December 3, 2006 - December 7, 2006.: NATURE PUBLISHING GROUP, December 1, 2006.  Link to Item
    • Mannelli, P, Patkar, A, Kuhn, C, and Perera, P. "Sodium oxybate for the treatment of fibromyalgia: A double-blind, placebo-controlled trial." 45th Annual Meeting of the American-College-of-Neuropsychopharmacolgy. Hollywood, FL. December 3, 2006 - December 7, 2006.: NATURE PUBLISHING GROUP, December 1, 2006.  Link to Item
    • Masand, PS, Pae, C-U, Peindl, K, Hooper-Wood, C, Ciccone, PE, Mannelli, P, and Patkar, AA. "A randomized, double-blind, placebo-controlled, flexible-dose, trial of augmentation with OROS methylphenidate in Treatment Resistant Depression." July 2006.  Link to Item
    • Mannelli, P, Gottheil, E, Thornton, C, Weinstein, S, and Levine, M. "Continuing care versus revolving door following opiate detoxification." : HAWORTH PRESS INC, January 1, 2003.  Link to Item
    • Mannelli, P, and Gottheil, E. "Very low antagonist dosing in opiate detoxification." : HAWORTH PRESS INC, January 1, 2001.  Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.